transparency
More Transparency in IRB-Industry Ties
More Transparency in IRB-Industry Ties
Kerry Grens | Jul 13, 2015
Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.
Device Trials Go Unpublished
Device Trials Go Unpublished
Kerry Grens | Jun 24, 2015
Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.
EPA Reform Bills Considered
EPA Reform Bills Considered
Kerry Grens | Mar 5, 2015
If passed, Republican-led efforts to change the US Environmental Protection Agency’s handling of science may never make it past the President’s desk.
IOM Urges Data Sharing
IOM Urges Data Sharing
Kerry Grens | Jan 15, 2015
The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.
Push For Data Disclosure
Push For Data Disclosure
Kerry Grens | Nov 21, 2014
Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.
EMA Gearing Up for Transparency
EMA Gearing Up for Transparency
Kerry Grens | Jun 16, 2014
The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  
More Openness on Lab Animals
More Openness on Lab Animals
Kerry Grens | May 15, 2014
Dozens of U.K. research groups agree to publicly disclose more information about their animal subjects.
J&J to Share Trial Data
J&J to Share Trial Data
Jef Akst | Jan 31, 2014
The pharmaceutical giant teams up with Yale University to make raw clinical data available to researchers.
Restoring Hidden Clinical Data
Restoring Hidden Clinical Data
Dan Cossins | Jun 18, 2013
Backed by two leading medical journals, researchers propose a new plan to publish clinical trial data that pharmaceutical companies often try to bury.
 
Clinical Trial Transparency in Europe?
Clinical Trial Transparency in Europe?
Bob Grant | Mar 28, 2013
The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.